Cardinal Health, Inc. $CAH Shares Purchased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 16.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 936,747 shares of the company’s stock after buying an additional 134,933 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Cardinal Health were worth $147,032,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Alliancebernstein L.P. boosted its holdings in shares of Cardinal Health by 0.9% in the first quarter. Alliancebernstein L.P. now owns 347,441 shares of the company’s stock valued at $47,867,000 after acquiring an additional 3,227 shares during the period. Integrated Wealth Concepts LLC raised its position in Cardinal Health by 6.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after purchasing an additional 280 shares during the last quarter. NewEdge Advisors LLC raised its position in Cardinal Health by 29.0% in the 1st quarter. NewEdge Advisors LLC now owns 16,037 shares of the company’s stock valued at $2,209,000 after purchasing an additional 3,608 shares during the last quarter. Nissay Asset Management Corp Japan ADV boosted its stake in Cardinal Health by 3.6% during the 1st quarter. Nissay Asset Management Corp Japan ADV now owns 31,224 shares of the company’s stock worth $4,302,000 after purchasing an additional 1,089 shares during the period. Finally, Jones Financial Companies Lllp grew its position in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.1%

Shares of CAH opened at $205.50 on Tuesday. The stock’s 50 day moving average is $201.82 and its two-hundred day moving average is $172.07. Cardinal Health, Inc. has a twelve month low of $119.00 and a twelve month high of $214.93. The firm has a market capitalization of $48.83 billion, a PE ratio of 31.00, a P/E/G ratio of 1.50 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The company’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is 30.77%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on CAH shares. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 8th. Leerink Partners boosted their price target on Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research report on Monday, November 17th. Citigroup upped their price objective on Cardinal Health from $165.00 to $190.00 and gave the company a “neutral” rating in a research note on Friday, October 31st. Argus lifted their target price on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Finally, Mizuho boosted their target price on Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a report on Monday, November 3rd. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $209.00.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.